SPI-256 is a novel compound under investigation for its potential applications in treating neurological disorders, particularly cognitive dysfunction and Alzheimer's disease. It functions as a selective modulator of certain receptors involved in brain signaling, aiming to enhance memory and learning processes. The mechanism of action of SPI-256 involves modulating neurotransmitter pathways, particularly those related to acetylcholine and glutamate, which play critical roles in cognitive function. Its therapeutic potential lies in its ability to improve synaptic plasticity and neuronal communication, which could help slow or mitigate the progression of cognitive decline in neurodegenerative diseases.
MedKoo Cat#: 145925
Name: SPI-256
CAS#: 869987-71-3
Chemical Formula: C33H43N3O10S
Exact Mass: 673.2700
Molecular Weight: 673.78
Elemental Analysis: C, 58.83; H, 6.43; N, 6.24; O, 23.75; S, 4.76
The following data is based on the product molecular weight 673.78 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
